Published in Gene Therapy Weekly, June 23rd, 2011
"Herein, we review strategies using this window as well as other promising work targeting IRI pathways using pharmacological treatments and gene therapy. Recent findings We highlight studies using molecules administered during kidney preservation to target key components of IRI such as inflammation, oxidative stress, mitochondrial activity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.